No black box warning on record for Entyvio

As of the latest FDA labeling reviewed, Entyvio (VEDOLIZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Entyvio medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions and Hypersensitivity Reactions : Discontinue ENTYVIO and initiate appropriate treatment if serious reactions occur. ( 5.1 ) Infections : Treatment with ENTYVIO should not be initiated in patients with a clinically important active infection until the infection resolves or is adequately treated. If a serious infection develops, ENTYVIO should no

No black box warning on record for Entyvio

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions and Hypersensitivity Reactions : Discontinue ENTYVIO and initiate appropriate treatment if serious reactions occur. ( 5.1 ) Infections : Treatment with ENTYVIO should not be initiated in patients with a clinically important active infection until the infection resolves or is adequately treated. If a serious infection develops, ENTYVIO should no

Entyvio Black Box Warning

No black box warning on record for Entyvio

Other warnings & precautions

Entyvio Black Box Warning

No black box warning on record for Entyvio

Other warnings & precautions